All Articles

Hyliion's appointment of defense guru Abdul Subhani isn't just a new hire; it's a calculated move to secure a central role in military energy resilience.

In a strategic move to dominate SMB digital banking, Axos Financial is buying AI-native fintech Arc. This isn't just an acquisition; it's a blueprint.

Beyond the hype, an AI assistant is quietly revolutionizing patient care. We explore how Counterpart Health's tool is bridging critical gaps and what it means for doctors and patients.

CDT Environmental regained Nasdaq compliance after a reverse stock split, but a look under the hood reveals financial strains and the persistent regulatory risks facing Chinese firms.

Del Monte and Treatt are turning fruit by-products into premium extracts, a savvy move that redefines sustainability as a profit center in the beverage industry.

Gartner's nod to Ez-XBRL is more than an award. It marks a shift to AI-native platforms that promise to turn the burden of compliance into a strategic asset.

Chicago's Midwest Film Festival expands to a five-day event, partnering with the historic Ramova Theatre to amplify the region's cinematic voices.

Amid soaring losses and a strategic overhaul, Core AI's appointment of CFO Arie Goor signals a critical bet on financial discipline to fuel its AI ambitions.

Atlantic Home Mortgage's new AI platform, Lendtrain, offers 30-second refi quotes. Its true innovation is a strategic shift from interest rates to break-even.

As Helius Minerals pushes to acquire Brazil's legendary Serra Pelada mine, a rival's legal victory resurrects old claims. But what does the ruling truly mean?

A Malaysian hotpot chain lands a massive data center deal, but with no tech experience and a plunging stock price, is this a brilliant pivot or a desperate gamble?

AstraZeneca's new deal with genomics firm Helix isn't just a partnership; it's a bet on a future where drug discovery is driven by massive data vaults.

With €33M in fresh capital, Cyllene Therapeutics is advancing a novel gene therapy for bladder disease. We analyze the tech, the investors, and the plan.

Presage Technologies' new FDA-cleared app turns any phone into a vital signs monitor, offering it free to hospitals to democratize healthcare access.

Lopesan Hotel Group just opened a massive three-resort complex in Punta Cana. Is it a new benchmark for luxury or a gamble too big to manage?

With its new Waybound™ brand, Delaware North is redefining outdoor lodging, blending upscale comfort with authentic nature experiences for discerning travelers.

A $170M recapitalization of Lone Peak Dental Group isn't just finance. It's a test of whether private credit can expand vital care for underserved kids.

The appointment of Robert Tidd is more than a new hire; it's a calculated move to master AI governance and redefine trust in a complex digital landscape.

Oregon's Tillamook isn't just winning awards; it's executing a masterclass in product innovation and brand strategy to challenge dairy giants.

Known for its athletic tape, KT is making a strategic leap into the crowded OTC pain relief aisle. Is this a brilliant brand extension or a risky bet?